Rayner Closes Recruitment for IDE for RayOne EMV Toric IOLs

Rayner announced that it has closed recruitment in the investigational device exemption (IDE) study for its EMV Toric IOL in the US.

The study will ultimately enable the introduction of the RayOne EMV Toric lens for use in the US. Developed in collaboration with Professor Graham Barrett, RayOne EMV’s non-diffractive optic utilizes positive spherical aberration to extend vision on the rotationally stable RayOne toric platform.[1}

“Closing recruitment on this study is a huge milestone for us. All patients will have their final follow ups well before the end of the year and the PMA submission will follow that," Jim Nevelos PhD, Head of Global Clinical at Rayner, said in a company news release. "This IDE will allow us to complete our range of the highly clinically successful RayOne EMV platform in the USA.” 

References

1. Bhogal-Bhamra GK, Sheppard AL, Kolli S, Wolffsohn JS. J Refract Surg. 2019;35(1):48-53.